Busca
Resultados da Busca
Select an image to start the slideshow
TLR9-Induced Antitumor Properties Are Dependent on CD2, an Underutilized yet Potent T Cell Costimulation Protein for Cancer Immunotherapies
1 of 8
Understanding immune-aging in myeloma and its precursor states
2 of 8
MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia immunity
3 of 8
Immunologic Mechanisms of Colorectal Liver Metastases: Potential for Novel Therapies
4 of 8
Enhancing Oncolytic Reovirus with Doxorubicin for Triple-Negative Breast Cancer Therapy
5 of 8
Investigating the Roles of ACLY in Multiple Myeloma Biology and Drug Sensitivity
6 of 8
PDGFB Is A Potent Inflammatory Driver In Pediatric High-Grade Glioma
7 of 8
Reprogramming the Immune Phenotype of Rb-deficient Prostate Cancer Cells via BET Inhibition
8 of 8